Are all hypotheses generated before data analysis prospective?

被引:4
作者
Urba, WJ [1 ]
Alvord, WG
机构
[1] Providence Portland Med Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA
[2] NCI, Data Management Serv Inc, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA
关键词
D O I
10.1200/JCO.2002.20.6.1431
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1431 / 1433
页数:3
相关论文
共 6 条
[1]   Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma [J].
Agarwala, SS ;
Glaspy, J ;
O'Day, SJ ;
Mitchell, M ;
Gutheil, J ;
Whitman, E ;
Gonzalez, R ;
Hersh, E ;
Feun, L ;
Belt, R ;
Meyskens, F ;
Hellstrand, K ;
Wood, D ;
Kirkwood, JM ;
Gehlsen, KR ;
Naredi, P .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :125-133
[2]   High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].
Atkins, MB ;
Lotze, MT ;
Dutcher, JP ;
Fisher, RI ;
Weiss, G ;
Margolin, K ;
Abrams, J ;
Sznol, M ;
Parkinson, D ;
Hawkins, M ;
Paradise, C ;
Kunkel, L ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116
[3]  
Barth A, 1995, J Am Coll Surg, V181, P193
[4]   Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684 [J].
Kirkwood, JM ;
Strawderman, MH ;
Ernstoff, MS ;
Smith, TJ ;
Borden, EC ;
Blum, RH .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :7-17
[5]  
Legha SS, 1997, CANCER J SCI AM, V3, pS9
[6]  
Tannock IF, 2000, J CLIN ONCOL, V18, p39S